Yasuhiro Oda Selected Research

Yasuhiro Oda Research Topics

Disease

2	Proteinuria 03/2022 - 01/2022
2	Inflammation (Inflammations) 11/2021 - 11/2019
2	Peritonitis 11/2021 - 01/2021
1	Joint Diseases (Joint Disease) 05/2023
1	Amyloidosis 05/2023
1	Arthralgia (Joint Pain) 05/2023
1	Pain (Aches) 05/2023
1	Fever (Fevers) 05/2023
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 04/2023
1	Disease Progression 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2022
1	Kidney Diseases (Kidney Disease) 03/2022
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 03/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hematuria 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Infections 11/2021
1	Mesenteric Ischemia 01/2021
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020
1	Seizures (Absence Seizure) 01/2020
1	Diabetic Foot 11/2019
1	Hypertension (High Blood Pressure) 11/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Essential Thrombocythemia 11/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2019
1	Starvation 01/2014
1	Neoplasms (Cancer) 07/2010
1	Anemia 07/2010
1	Gastroparesis 09/2008
1	Liver Failure 09/2008
1	Body Weight (Weight, Body) 09/2008
1	Renal Insufficiency (Renal Failure) 09/2008
1	Hyperglycemia 09/2008

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2008
1	Amyloid (Amyloid Fibrils)IBA 05/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2023
1	Prednisolone (Predate)FDA LinkGeneric 05/2023
1	Immunoglobulin G (IgG)IBA 04/2023
1	SodiumIBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	GlucocorticoidsIBA 03/2022
1	CollagenIBA 03/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	CreatinineIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	Ceftazidime (Fortum)FDA LinkGeneric 11/2021
1	Cefazolin (Ancef)FDA LinkGeneric 11/2021
1	AntibodiesIBA 01/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	Dialysis SolutionsIBA 01/2021
1	Triazolam (Halcion)FDA LinkGeneric 03/2020
1	Modafinil (Provigil)FDA Link 03/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 11/2019
1	Inosine Triphosphate (ITP)IBA 11/2019
1	NitrogenIBA 01/2014
1	Reducing AgentsIBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 07/2010
1	Streptozocin (Streptozotocin)FDA Link 09/2008
1	Insulin (Novolin)FDA Link 09/2008
1	mitemcinalIBA 09/2008

Therapy/Procedure

2	Peritoneal Dialysis 11/2021 - 01/2021
1	Renal Dialysis (Hemodialysis) 05/2023
1	Intravenous Administration 11/2021
1	Glycemic Control 11/2019
1	Surgical Amputation (Amputations) 11/2019
1	Intravenous Injections 09/2008